Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cytotoxicity of synthetic derivatives against breast cancer and multi-drug resistant breast cancer cell lines: a literature-based perspective study
Shabnam Sharmin, Md. Mizanur Rahaman, Miquel Martorell, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Multifunctional Carbon-Based Nanoparticles: Theranostic Applications in Cancer Therapy and Diagnosis
Seyed Mohammad Hosseini, Javad Mohammadnejad, Roqya Najafi-Taher, et al.
ACS Applied Bio Materials (2023) Vol. 6, Iss. 4, pp. 1323-1338
Closed Access | Times Cited: 23
Nanoparticle drug delivery systems responsive to tumor microenvironment: Promising alternatives in the treatment of triple‐negative breast cancer
Ye Cao, Fansu Meng, Tiange Cai, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 4
Benzoxazole-appended piperidine derivatives as novel anticancer candidates against breast cancer
Omaima M. Aboulwafa, Hoda G. Daabees, Ahmed H. El-Said
Bioorganic Chemistry (2023) Vol. 134, pp. 106437-106437
Closed Access | Times Cited: 10
New 1H-1,2,3-Triazole Analogues of Boswellic Acid are Potential Anti-Breast Cancer Agents
Satya Kumar Avula, Najeeb Ur Rehman, Faizullah Khan, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139447-139447
Closed Access | Times Cited: 2
Docosahexaenoic Acid, a Key Compound for Enhancing Sensitization to Drug in Doxorubicin-Resistant MCF-7 Cell Line
Sérgio Crovella, Allal Ouhtit, Shaikh Mizanoor Rahman, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1658-1658
Open Access | Times Cited: 7
Hypophyllanthin and Phyllanthin from Phyllanthus niruri Synergize Doxorubicin Anticancer Properties against Resistant Breast Cancer Cells
Ola E. Abdel-Sattar, Rasha M. Allam, Ahmed M. Al‐Abd, et al.
ACS Omega (2023) Vol. 8, Iss. 31, pp. 28563-28576
Open Access | Times Cited: 7
The Cytotoxicity of Carbon Nanotubes and Hydroxyapatite, and Graphene and Hydroxyapatite Nanocomposites against Breast Cancer Cells
Tristan Nguyen, Anuj Maniyar, Mrinmoy Sarkar, et al.
Nanomaterials (2023) Vol. 13, Iss. 3, pp. 556-556
Open Access | Times Cited: 6
Optimizing combination therapy in a murine model of HER2+ breast cancer
Ernesto A. B. F. Lima, Reid A.F. Wyde, Anna G. Sorace, et al.
Computer Methods in Applied Mechanics and Engineering (2022) Vol. 402, pp. 115484-115484
Open Access | Times Cited: 10
Design, combinatorial synthesis and cytotoxic activity of 2-substituted furo[2,3-d]pyrimidinone and pyrrolo[2,3-d]pyrimidinone library
Buer Song, Lifei Nie, Khurshed Bozorov, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1767-1783
Closed Access | Times Cited: 8
Insights on Lipomatosis after Platinum-Based Chemotherapy Use in Pediatric Oncology: A Case Report
Estera Boeriu, Alexandra Georgiana Boc, Alexandra Borda, et al.
Medicina (2022) Vol. 58, Iss. 12, pp. 1715-1715
Open Access | Times Cited: 5
Heavy Metal Complexes of 1, 2, 3-Triazole derivative: Synthesis, Characterization, and Cytotoxicity Appraisal Against Breast Cancer Cell Lines (MDA-MB-231)
Jihan Hameed Abdulameer, M. F. A. Alias
Baghdad Science Journal (2022) Vol. 19, Iss. 6(Suppl.), pp. 1410-1410
Open Access | Times Cited: 5
Synthesis of tricyclic and tetracyclic benzo[6,7]cycloheptane derivatives linked morpholine moiety as CDK2 inhibitors
Thoraya A. Farghaly, Eman M. H. Abbas, Mariam A. Al‐Sheikh, et al.
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1127-1141
Closed Access | Times Cited: 2
Styrylpyridinium Derivatives for Fluorescent Cell Imaging
Reinis Putralis, Ksenija Korotkaja, Martins Kaukulis, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1245-1245
Open Access | Times Cited: 2
Organic Nanomaterials Loaded with Cytotoxic Agents: A Therapeutic Alternative Against Cancer
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Diego E. Navarro-López, et al.
Interdisciplinary cancer research (2024)
Closed Access
Halogen‐based quinazolin‐4(3H)‐one derivatives as MCF‐7 breast cancer inhibitors: Current developments and structure–activity relationship
Rachana Upadhyay, P. K. Tandel, Amit B. Patel
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Synthesis, optimization, characterization, anti-oxidant and anti-cancerous activity analysis of nanoparticles IA-AuNPs synthesized using leaf extract of soil grown Ipomoea aquatica
Avinash Kumar Chaurasia, Ritika Kumari Singh, Arvind Kumar
Journal of Molecular Structure (2024), pp. 141212-141212
Closed Access
Analysing potent biomarkers along phytochemicals for breast cancer therapy: an in silico approach
N. Chandra Shekar, Paton Vuong, Parwinder Kaur
Breast Cancer Research and Treatment (2023)
Open Access | Times Cited: 1
‘Synthesis, antiviral activity, molecular docking, and molecular dynamics studies of ethoxy phthalimide pyrazole derivatives against Cytomegalovirus and Varicella-Zoster virus: potential consequences and strategies for developing new antiviral treatments’
Abhishek Verma, Vipin K. Yadav, Ali Asger Bhojiya, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 24, pp. 13903-13922
Closed Access | Times Cited: 1
Page 1

Scroll to top